Shots: This BLA is for the treatment of RA, PsA, AS, CD, UC, chronic psoriasis, HS, and JIA The clinical study included (PK/PD) and Ph III trials in ankylosing spondylitis showing its safety, efficacy and quality Bio-Thera is developing 7 biosimilars including BAT1406, with Avastin biosimilar currently being assessed in a global Ph III […]Read More
Tags : Biosimilar BAT1406
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US